256 related articles for article (PubMed ID: 26410289)
1. Highlights of the 28(th) North American Cystic Fibrosis Conference 2014.
Nwokoro CE
Paediatr Respir Rev; 2015 Oct; 16 Suppl 1():12-4. PubMed ID: 26410289
[TBL] [Abstract][Full Text] [Related]
2. Highlights of the North American CF Conference 2013.
Walshaw M
Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():8-9. PubMed ID: 24821547
[TBL] [Abstract][Full Text] [Related]
3. Highlights from the 30th North American Cystic Fibrosis Conference, Orlando 2016.
Shawcross A; Barry PJ
Paediatr Respir Rev; 2018 Mar; 26():1-3. PubMed ID: 28400241
[TBL] [Abstract][Full Text] [Related]
4. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
Barrio R
Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.
Fredj SH; Messaoud T; Templin C; des Georges M; Fattoum S; Claustres M
Genet Test Mol Biomarkers; 2009 Oct; 13(5):577-81. PubMed ID: 19715466
[TBL] [Abstract][Full Text] [Related]
6. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
7. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes.
Stalvey MS; Brusko TM; Mueller C; Wasserfall CH; Schatz DA; Atkinson MA; Flotte TR
Cytokine; 2008 Oct; 44(1):154-9. PubMed ID: 18778952
[TBL] [Abstract][Full Text] [Related]
8. Highlights from the 2015 North American Cystic Fibrosis Conference.
Zemanick ET; Ong T; Daines CL; Dellon EP; Muhlebach MS; Esther CR
Pediatr Pulmonol; 2016 Jun; 51(6):650-7. PubMed ID: 27074261
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis related diabetes in an extremely young patient.
Casas L; Berry DR; Logan K; Copeland KC; Royall JA
J Cyst Fibros; 2007 May; 6(3):247-9. PubMed ID: 17092782
[TBL] [Abstract][Full Text] [Related]
10. Cystic Fibrosis Diagnosis and Newborn Screening.
Rosenfeld M; Sontag MK; Ren CL
Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
[TBL] [Abstract][Full Text] [Related]
11. CF versus CRMS: diagnostic challenges in cystic fibrosis.
Temme R; Roggenbuck J; McNamara J
Minn Med; 2012 Oct; 95(10):42-4. PubMed ID: 23193705
[TBL] [Abstract][Full Text] [Related]
12. First report of cystic fibrosis mutations in Libyan cystic fibrosis patients.
Hadj Fredj S; Fattoum S; Chabchoub A; Messaoud T
Ann Hum Biol; 2011 Sep; 38(5):561-3. PubMed ID: 21329479
[TBL] [Abstract][Full Text] [Related]
13. Fundamental and translational research in Cystic Fibrosis - why we still need it.
Farinha CM; Brodsky JL; Pedemonte N
J Cyst Fibros; 2023 Mar; 22 Suppl 1():S1-S4. PubMed ID: 36577595
[TBL] [Abstract][Full Text] [Related]
14. Equivalent substrates enable simultaneous study of gastrointestinal pH and CF-related diabetes.
Borowitz D; Gelfond D
J Cyst Fibros; 2015 Jul; 14(4):e6-8. PubMed ID: 25698452
[No Abstract] [Full Text] [Related]
15. Radiological analysis of children with cystic fibrosis who are homozygous for cystic fibrosis transmembrane conductance regulator mutation S549R (T-->G).
Frossard PM; Bakalinova D; Hertecant J; Bossaert Y; Dawson KP
J Trop Pediatr; 1999 Jun; 45(3):158-60. PubMed ID: 10401194
[TBL] [Abstract][Full Text] [Related]
16. mGluR1 interacts with cystic fibrosis transmembrane conductance regulator and modulates the secretion of IL-10 in cystic fibrosis peripheral lymphocytes.
Shanshiashvili LV; Dabrundashvili N; Natsvlishvili N; Kvaratskhelia E; Zhuravliova E; Barbakadze T; Koriauli S; Maisuradze E; Topuria T; Mikeladze DG
Mol Immunol; 2012 Jul; 51(3-4):310-5. PubMed ID: 22520513
[TBL] [Abstract][Full Text] [Related]
17. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus in cystic fibrosis.
Hardin DS; Moran A
Endocrinol Metab Clin North Am; 1999 Dec; 28(4):787-800, ix. PubMed ID: 10609120
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of the cystic fibrosis transmembrane regulator in chronic sinusitis in cystic fibrosis and non-cystic fibrosis patients.
Coltrera MD; Mathison SM; Goodpaster TA; Gown AM
Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):576-81. PubMed ID: 10378526
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Ren CL; Desai H; Platt M; Dixon M
Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
